Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Gains from Investment Securities (2016 - 2025)

Macrogenics (MGNX) has disclosed Gains from Investment Securities for 12 consecutive years, with $288000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 88.1% to $288000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $288000.0, a 88.36% decrease, with the full-year FY2025 number at $288000.0, down 88.36% from a year prior.
  • Gains from Investment Securities was $288000.0 for Q4 2025 at Macrogenics, up from -$282000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.9 million in Q4 2022 to a low of -$2.4 million in Q2 2024.
  • A 5-year average of $68933.3 and a median of $76000.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 1413.29% in 2024; the steepest drop was 385.31% in 2024.
  • Macrogenics' Gains from Investment Securities stood at -$433000.0 in 2021, then surged by 765.59% to $2.9 million in 2022, then tumbled by 77.62% to $645000.0 in 2023, then surged by 275.19% to $2.4 million in 2024, then plummeted by 88.1% to $288000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Gains from Investment Securities are $288000.0 (Q4 2025), -$282000.0 (Q2 2025), and $282000.0 (Q1 2025).